APM

APM

Aptorum Group Ltd Class A

Aptorum Group Limited is a clinical-stage biopharmaceutical company focused on developing therapeutic products for oncology and infectious diseases, including drug candidates for neuroblastoma, bacterial infections, and coronavirus, along with diagnostic solutions.

โš•๏ธ Healthcare NASDAQ Listed 2018 $ USD
$1,000 invested 5 years ago โ†’$32,724today

Score Overview

1 Year
Scoreโ€”
Net Growth-5x
Net TrendShrank
Net Income Consistencyโ€”
Rev Growthโ€”
Rev TrendGrew
Revenue Consistencyโ€”
5 Years
Score4.6
Net Growth64.34%
Net Trend60%
Net Income Consistencyโ€”
Rev Growth-37.69%
Rev Trend20%
Revenue Consistencyโ€”
All Time
Score3.1
Net Growth39.77%
Net Trend50%
Net Income ConsistencyInconsistent
Rev Growth150.57%
Rev Trend50%
Revenue Consistency6%

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-07-27
$ 8.41โ€”
5 Years2021-07-29
$ 0.2632x
All Time2018-12-18
$ 14.35-41.39%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2026$ 960.82K-$ 8M$ 3M
2025$ 0.00-$ 1M$ 3M
2024$ 0.00-$ 4M$ 874.24K
2023$ 431.38K-$ 2M$ 2M
2022$ 1M-$ 9M$ 1M
2021$ 1M-$ 25M$ 8M
2020$ 911.51K$ 7M$ 31M
2019$ 535.17K-$ 18M$ 6M
IPO2018$ 383.45K-$ 14M$ 13M